Pancreatic Cancer Research

ResearcherSakarya UniversityNo recent work listed

Cemil Bilir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1372-4791; OpenAlex author ID A5014573721. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT. Last author DOI 10.2174/1573405618666220303105410↗
  2. ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. First author DOI 10.7314/apjcp.2012.13.1.131↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bahattin Özkul · 1 shared paper, 2022 · strength 0.26
  2. Hüseyin Engin · 1 shared paper, 2012 · strength 0.04
  3. Ayla Gökmen · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.